G protein-coupled receptor 39 deficiency is associated with pancreatic islet dysfunction

Birgitte Holst; Kristoffer L Egerod; Chunyu Jin; Pia Steen Petersen; Mette Viberg Østergaard; Jacob Hald; A M Ejernaes Sprinkel; Joachim Størling; Thomas Mandrup-Poulsen; Jens J Holst; Peter Thams; Cathrine Orskov; Nils Wierup; Frank Sundler; Ole D Madsen; Thue W Schwartz

doi:10.1210/en.2008-1250

G protein-coupled receptor 39 deficiency is associated with pancreatic islet dysfunction

Birgitte Holst, Kristoffer L Egerod, Chunyu Jin, Pia Steen Petersen, Mette Viberg Østergaard, Jacob Hald, A M Ejernaes Sprinkel, Joachim Størling, Thomas Mandrup-Poulsen, Jens J Holst, Peter Thams, Cathrine Orskov, Nils Wierup, Frank Sundler, Ole D Madsen, Thue W Schwartz

65 Citations (Scopus)

Abstract

G protein-coupled receptor (GPR)-39 is a seven-transmembrane receptor expressed mainly in endocrine and metabolic tissues that acts as a Zn(++) sensor signaling mainly through the G(q) and G(12/13) pathways. The expression of GPR39 is regulated by hepatocyte nuclear factor (HNF)-1alpha and HNF-4alpha, and in the present study, we addressed the importance of GPR39 for glucose homeostasis and pancreatic islets function. The expression and localization of GPR39 were characterized in the endocrine pancreas and pancreatic cell lines. Gpr39(-/-) mice were studied in vivo, especially in respect of glucose tolerance and insulin sensitivity, and in vitro in respect of islet architecture, gene expression, and insulin secretion. Gpr39 was down-regulated on differentiation of the pluripotent pancreatic cell line AR42J cells toward the exocrine phenotype but was along with Pdx-1 strongly up-regulated on differentiation toward the endocrine phenotype. Immunohistochemistry demonstrated that GRP39 is localized selectively in the insulin-storing cells of the pancreatic islets as well as in the duct cells of the exocrine pancreas. Gpr39(-/-) mice displayed normal insulin sensitivity but moderately impaired glucose tolerance both during oral and iv glucose tolerance tests, and Gpr39(-/-) mice had decreased plasma insulin response to oral glucose. Islet architecture was normal in the Gpr39 null mice, but expression of Pdx-1 and Hnf-1alpha was reduced. Isolated, perifused islets from Gpr39 null mice secreted less insulin in response to glucose stimulation than islets from wild-type littermates. It is concluded that GPR39 is involved in the control of endocrine pancreatic function, and it is suggested that this receptor could be a novel potential target for the treatment of diabetes.

Original language	English
Journal	Endocrinology
Volume	150
Issue number	6
Pages (from-to)	2577-85
Number of pages	8
ISSN	0013-7227
DOIs	https://doi.org/10.1210/en.2008-1250
Publication status	Published - 2009

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1210/en.2008-1250

Cite this

Holst, B., Egerod, K. L., Jin, C., Petersen, P. S., Østergaard, M. V., Hald, J., Sprinkel, A. M. E., Størling, J., Mandrup-Poulsen, T., Holst, J. J., Thams, P., Orskov, C., Wierup, N., Sundler, F., Madsen, O. D., & Schwartz, T. W. (2009). G protein-coupled receptor 39 deficiency is associated with pancreatic islet dysfunction. Endocrinology, 150(6), 2577-85. https://doi.org/10.1210/en.2008-1250

Holst, B , Egerod, KL, Jin, C, Petersen, PS, Østergaard, MV, Hald, J, Sprinkel, AME, Størling, J, Mandrup-Poulsen, T , Holst, JJ, Thams, P, Orskov, C, Wierup, N, Sundler, F, Madsen, OD & Schwartz, TW 2009, 'G protein-coupled receptor 39 deficiency is associated with pancreatic islet dysfunction', Endocrinology, vol. 150, no. 6, pp. 2577-85. https://doi.org/10.1210/en.2008-1250

@article{1c8f6d90335611df8ed1000ea68e967b,

title = "G protein-coupled receptor 39 deficiency is associated with pancreatic islet dysfunction",

abstract = "G protein-coupled receptor (GPR)-39 is a seven-transmembrane receptor expressed mainly in endocrine and metabolic tissues that acts as a Zn(++) sensor signaling mainly through the G(q) and G(12/13) pathways. The expression of GPR39 is regulated by hepatocyte nuclear factor (HNF)-1alpha and HNF-4alpha, and in the present study, we addressed the importance of GPR39 for glucose homeostasis and pancreatic islets function. The expression and localization of GPR39 were characterized in the endocrine pancreas and pancreatic cell lines. Gpr39(-/-) mice were studied in vivo, especially in respect of glucose tolerance and insulin sensitivity, and in vitro in respect of islet architecture, gene expression, and insulin secretion. Gpr39 was down-regulated on differentiation of the pluripotent pancreatic cell line AR42J cells toward the exocrine phenotype but was along with Pdx-1 strongly up-regulated on differentiation toward the endocrine phenotype. Immunohistochemistry demonstrated that GRP39 is localized selectively in the insulin-storing cells of the pancreatic islets as well as in the duct cells of the exocrine pancreas. Gpr39(-/-) mice displayed normal insulin sensitivity but moderately impaired glucose tolerance both during oral and iv glucose tolerance tests, and Gpr39(-/-) mice had decreased plasma insulin response to oral glucose. Islet architecture was normal in the Gpr39 null mice, but expression of Pdx-1 and Hnf-1alpha was reduced. Isolated, perifused islets from Gpr39 null mice secreted less insulin in response to glucose stimulation than islets from wild-type littermates. It is concluded that GPR39 is involved in the control of endocrine pancreatic function, and it is suggested that this receptor could be a novel potential target for the treatment of diabetes.",

author = "Birgitte Holst and Egerod, {Kristoffer L} and Chunyu Jin and Petersen, {Pia Steen} and {\O}stergaard, {Mette Viberg} and Jacob Hald and Sprinkel, {A M Ejernaes} and Joachim St{\o}rling and Thomas Mandrup-Poulsen and Holst, {Jens J} and Peter Thams and Cathrine Orskov and Nils Wierup and Frank Sundler and Madsen, {Ole D} and Schwartz, {Thue W}",

note = "Keywords: Animals; Cells, Cultured; Disease Models, Animal; Female; Glucose; Hepatocyte Nuclear Factor 1-alpha; Homeodomain Proteins; Homeostasis; Insulin; Islets of Langerhans; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Phenotype; Receptors, G-Protein-Coupled; Signal Transduction; Trans-Activators; Zinc",

year = "2009",

doi = "10.1210/en.2008-1250",

language = "English",

volume = "150",

pages = "2577--85",

journal = "Journal of Clinical Endocrinology and Metabolism",

issn = "0013-7227",

publisher = "Oxford University Press",

number = "6",

}

TY - JOUR

T1 - G protein-coupled receptor 39 deficiency is associated with pancreatic islet dysfunction

AU - Holst, Birgitte

AU - Egerod, Kristoffer L

AU - Jin, Chunyu

AU - Petersen, Pia Steen

AU - Østergaard, Mette Viberg

AU - Hald, Jacob

AU - Sprinkel, A M Ejernaes

AU - Størling, Joachim

AU - Mandrup-Poulsen, Thomas

AU - Holst, Jens J

AU - Thams, Peter

AU - Orskov, Cathrine

AU - Wierup, Nils

AU - Sundler, Frank

AU - Madsen, Ole D

AU - Schwartz, Thue W

N1 - Keywords: Animals; Cells, Cultured; Disease Models, Animal; Female; Glucose; Hepatocyte Nuclear Factor 1-alpha; Homeodomain Proteins; Homeostasis; Insulin; Islets of Langerhans; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Phenotype; Receptors, G-Protein-Coupled; Signal Transduction; Trans-Activators; Zinc

PY - 2009

Y1 - 2009

N2 - G protein-coupled receptor (GPR)-39 is a seven-transmembrane receptor expressed mainly in endocrine and metabolic tissues that acts as a Zn(++) sensor signaling mainly through the G(q) and G(12/13) pathways. The expression of GPR39 is regulated by hepatocyte nuclear factor (HNF)-1alpha and HNF-4alpha, and in the present study, we addressed the importance of GPR39 for glucose homeostasis and pancreatic islets function. The expression and localization of GPR39 were characterized in the endocrine pancreas and pancreatic cell lines. Gpr39(-/-) mice were studied in vivo, especially in respect of glucose tolerance and insulin sensitivity, and in vitro in respect of islet architecture, gene expression, and insulin secretion. Gpr39 was down-regulated on differentiation of the pluripotent pancreatic cell line AR42J cells toward the exocrine phenotype but was along with Pdx-1 strongly up-regulated on differentiation toward the endocrine phenotype. Immunohistochemistry demonstrated that GRP39 is localized selectively in the insulin-storing cells of the pancreatic islets as well as in the duct cells of the exocrine pancreas. Gpr39(-/-) mice displayed normal insulin sensitivity but moderately impaired glucose tolerance both during oral and iv glucose tolerance tests, and Gpr39(-/-) mice had decreased plasma insulin response to oral glucose. Islet architecture was normal in the Gpr39 null mice, but expression of Pdx-1 and Hnf-1alpha was reduced. Isolated, perifused islets from Gpr39 null mice secreted less insulin in response to glucose stimulation than islets from wild-type littermates. It is concluded that GPR39 is involved in the control of endocrine pancreatic function, and it is suggested that this receptor could be a novel potential target for the treatment of diabetes.

AB - G protein-coupled receptor (GPR)-39 is a seven-transmembrane receptor expressed mainly in endocrine and metabolic tissues that acts as a Zn(++) sensor signaling mainly through the G(q) and G(12/13) pathways. The expression of GPR39 is regulated by hepatocyte nuclear factor (HNF)-1alpha and HNF-4alpha, and in the present study, we addressed the importance of GPR39 for glucose homeostasis and pancreatic islets function. The expression and localization of GPR39 were characterized in the endocrine pancreas and pancreatic cell lines. Gpr39(-/-) mice were studied in vivo, especially in respect of glucose tolerance and insulin sensitivity, and in vitro in respect of islet architecture, gene expression, and insulin secretion. Gpr39 was down-regulated on differentiation of the pluripotent pancreatic cell line AR42J cells toward the exocrine phenotype but was along with Pdx-1 strongly up-regulated on differentiation toward the endocrine phenotype. Immunohistochemistry demonstrated that GRP39 is localized selectively in the insulin-storing cells of the pancreatic islets as well as in the duct cells of the exocrine pancreas. Gpr39(-/-) mice displayed normal insulin sensitivity but moderately impaired glucose tolerance both during oral and iv glucose tolerance tests, and Gpr39(-/-) mice had decreased plasma insulin response to oral glucose. Islet architecture was normal in the Gpr39 null mice, but expression of Pdx-1 and Hnf-1alpha was reduced. Isolated, perifused islets from Gpr39 null mice secreted less insulin in response to glucose stimulation than islets from wild-type littermates. It is concluded that GPR39 is involved in the control of endocrine pancreatic function, and it is suggested that this receptor could be a novel potential target for the treatment of diabetes.

U2 - 10.1210/en.2008-1250

DO - 10.1210/en.2008-1250

M3 - Journal article

C2 - 19213833

SN - 0013-7227

VL - 150

SP - 2577

EP - 2585

JO - Journal of Clinical Endocrinology and Metabolism

JF - Journal of Clinical Endocrinology and Metabolism

IS - 6

ER -

G protein-coupled receptor 39 deficiency is associated with pancreatic islet dysfunction

Abstract

UN SDGs

Access to Document

Fingerprint

Cite this